Abstracts of Presentations from the 2020 Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat the Acute and Chronic Effects of Ocular Chemical Toxicity, 25-26 February, Bethesda, Maryland
Toxicol Lett. 2020 May 25:1-3.
doi: 10.1016/j.toxlet.2020.05.026.
Online ahead of print.
1 Department of Health and Human Services, National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), 5601 Fishers Lane (1G58), Bethesda, MA, 20892, USA. Electronic address: dy70v@nih.gov.
2 Department of Health and Human Services, National Eye Institute/National Institutes of Health (NEI/NIH), 6700B Rockledge Dr (Suite 3400), Bethesda, MA, 20817, USA. Electronic address: houmam.araj@nih.gov.
3 Department of Defense, United States Army Medical Research Institute of Chemical Defense (USAMRICD), 2900 Ricketts Point Road, Aberdeen Proving Ground, MA, 21010, USA. Electronic address: patrick.m.mcnutt2.civ@mail.mil.